(MedPage Today) — Women should be better informed about the potential risks of using selective serotonin reuptake inhibitors (SSRIs) during pregnancy, and these risks should be weighed against their benefits, most speakers on an FDA panel selected…
Source link : https://www.medpagetoday.com/psychiatry/depression/116610
Author :
Publish date : 2025-07-21 21:17:00
Copyright for syndicated content belongs to the linked Source.
